Simultaneous Detection of BCL-2 Protein, Trisomy 12, Retinoblastoma and P53 Monoallelic Gene Deletions in B-Cell Chronic Lymphocytic Leukemia by Fluorescence in Situ Hybridization (FISH): Relation to Disease Status

References

• Korsmeyer S. J. Bcl-2 Initiates a New Category of Oncogenes: Regulators of Cell Death. Review article. Blood 1992; 80: 879–886
   PubMed Web of Science ®Google Scholar
• Hannum Y. A. Apoptosis and the Dilemma of Cancer Chemotherapy. Review article. Blood 1997; 89: 1845–1853
   PubMed Web of Science ®Google Scholar
• Dyer M. J. S., Zani V. J., Lu W. Z., O'Byrne A., Mould S., Chapman R., Heward J.M., Kayano H., Jadayel D., Mat-utes E., Catovsky D., Oscier D. G. BCL2 Trans-locations in Leukemias of Mature B Cells. Blood 1994; 83: 3682–3688
   PubMed Web of Science ®Google Scholar
• Miyashita T., Krajewski S., Krajewska M., Hong Gang Wang, Lin H. K., Liebermann Dan A, Hoffman B, Reed J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799–1805
   PubMed Web of Science ®Google Scholar
• Miyashita T., Reed J. C. Tumor Suppressor p53 is a Direct Transcriptional Activator of the Human bax Gene. Cell 1995; Vol. 80: 293–-299
   Web of Science ®Google Scholar
• Carson D. A., Ribeiro J. M. Apoptosis and disease. Review Article. The Lancet 1993; 341: 1251–1254
   PubMed Web of Science ®Google Scholar
• Hartwell L. H., Kastan M. B. Cell Cycle Control and Cancer. Science 1994; 266: 1821–182, 8
   PubMed Web of Science ®Google Scholar
• Hirama T., Koeffler H P. Role of the Cyclin-Dependent Kinase Inhibitors in the Development of Cancer. Blood 1995; 86: 841–854
   PubMed Web of Science ®Google Scholar
• Hanada M., Delia D., Aiello A., Stadtmauer E., Reed J. C. Bcl-2 Gene Hypomethylation and High-Level Expression in B-Cell Chronic Lymphocytic Leukemia. Blood 1996; 82: 1820–1828
   Google Scholar
• Dighiero G., Binet J-L. Chronic lymphocytic leukemia. Hematology and Cell Therapy 1996; 38: 541–561
   Google Scholar
• Stilgenbauer S., Dohner H., Bulgary- Morschel M., Weitz S., Bentz M., Lichter P. High Frequency of Monoal-lelic Retinoblastoma Gene Deletion in B-Cell Chronic Lym-phoid Leukemia shown by Interphase Cytogenetics. Blood 1993; 81: 2118–2124
   PubMed Web of Science ®Google Scholar
• O'Brien S., del Giglio Auro, Keating M. Advances in the Biology and Treatment of B-Cell Chronic Lymphocytic Leukemia. Blood 1995; 85: 307–318
   PubMed Web of Science ®Google Scholar
• Dohner H., Fischer K., Benz M., Hansen K., Lichter P. P53 Gene Deletion Predicts for Poor Survival and Non-Response to Therapy With Purine Analogs in Chronic B- Cell Leukemias. Blood 1995; 85: 1580–1589
   PubMed Web of Science ®Google Scholar
• Lishner M., Arbov L, Manor Y., Elis A., Amiel A. Monoallelic p53 Deletions in CLL detected by interphase cytogenetics. Blood 1996; 88(suppl. 1)238a
   Google Scholar
• Catovsky D., Murphy R. L.W. Key Issues in the Treatment of Chronic Lymphocytic Leukemia (CLL). European Journal of Cancer 1995; 31A: 2146–2154
   PubMed Web of Science ®Google Scholar
• Schlaifer D., Brousset P., Attal M., Massip P., Payen C., Mar-chou B., Huguet F., Muller C., Laurant G., Pris J., Delsol G. bcl-2 protooncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma. Histopatohlogy 1994; 25: 77–82
   PubMed Web of Science ®Google Scholar
• Garicochea G., Chase A., Lazaridou A., Goldman J. M. T Lymphocytes in Chronic Myelogenous Leukemia (CML): No evidence of the bcr/abl Fusion Gene Detected by Fluoresence in Situ Hybridization in 14 Patients. Lekuemia 1994; 8: 1197–1201
   PubMed Web of Science ®Google Scholar
• Reining G., Clodi K., Konig M., Geissler K., Haas O. A., Mannhalter C. Detection of trisomy 12 in chronic lymphocytic leukemia: comparison of a polymerase chain reaction based technique with fluorescence in situ hybridization. British Journal of Haemaotlogy 1994; 87: 843–845
   PubMed Web of Science ®Google Scholar
• Daniel W. P. Biostatistics: a foundation for analysis in the health sciences. John Wiley and Sons, New York 1991
   Google Scholar
• Kaplan E. Non parametric estimation from incomplete observations. Journal of American Statistics Assocaition 1958; 53: 457–481, L and Mayer
   Web of Science ®Google Scholar
• Losada A. P., Wessman M., Tiaenen M., Hopman A. H.N., Willard H. F., Sole F., Caballin M. R., Woessner S., Knuutila S. Trisomy 12 in Chronic Lymphocytic Leukemia: An Interphase Cytogenetic Study. Blodo 1991; 78: 775–777
   PubMed Web of Science ®Google Scholar
• Garcia-Marco J., Matutes E., Morilla R., Ellis J., Oscier D., Fames J., Catovsy D. Trisomy 12 in B-cell chronic lymphocytic leukemia: Assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization. British Journal of Haemaotlogy 1994; 87: 44–50
   PubMed Web of Science ®Google Scholar
• Avet-Loiseau H., Devider M. C., Garand R., Bouyge L., Rapp M. J., Ilipied N., Bataille R. 13q14 Deletions are not primary events in B-cell Chronic Lymphocytic Leukemia and are rarely (but possibly) Associated with trisomy 12. British Journal of Haemaotlogy 1996; 93: 154
   PubMed Web of Science ®Google Scholar
• Garcia Marco J. A., Navarro B., Bowen A., Price C M, Catovsky D. Trisomy 12 and 13q14 Deletions are Frequently Found Associated in Chronic Lymphocytic Leukemias (CLL). British Journal of Haemaotlogy 1997; 38: 103
   Google Scholar
• Bullrich F, Veronese M. L., Kitada S., Croce C. M. Minimal Region of Loss at 13q14 in B-Cell Chronic Lymphocytic Leukemia. Blodo 1996; 88: 3109–3115
   PubMed Web of Science ®Google Scholar
• Geisler C H, Philip P, Egelund Ch.B, Hou-Jensen K, Ting-gaard Pedersen N, Myhre J, Thorling K, Andersen F., Bir-geans H., Nielsen H., Ellegaard J., Larsen J K, Brown P, Kragh Andersen P., Mork Hansen M. Trisomy 12 found in CLL with both typical and atypikal immunophenotype and has no prognostic significance. VII International Workshop on CLL, abstrac tbook 1997; 21: 2–4
   Google Scholar
• Dierlamn J., Michaux L, Criel A, Wlodarska I, den Berghe Van, Hossfeld D K. Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications. Cancer Genetics Cytogeentics 1997; 94: 27–35
   PubMed Web of Science ®Google Scholar
• Garcia-Marco J. A., Navaro B., Bowen A., Matutes E., Oscier D., Catovsky D. Prognostic index in CLL. Blodo 1998; 92(suppl. 1)515a
   Google Scholar
• Concoran M M, Rasool O, Liu Y, et al. Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blodo 1998; 91: 1382–1390
   PubMed Web of Science ®Google Scholar
• Neubauer A., De Kant E., Ch Rochlitz, Laser J., Zanrtta A. M., Dieter H. Altered expression of the retinoblastoma susceptibility gene in chronic lymphocytic leukaemia. British Journal of Haemaotlogy 1993; 85: 498–503
   PubMed Web of Science ®Google Scholar
• Kornblau S. M., Chen N., del Giglio A., Brien O., Deisseroth A. B. Retinoblastoma Protein Expression Is Frequently Altered in Chronic Lymphocytic Leukemia. Cancer Reesarch 1994; 54: 242–246
   PubMed Web of Science ®Google Scholar
• Roubi S. El, Thomas A., Costin D., Newcomb E. W. p53 Gene mutation in B-Cell Chronic Lymphocytic Leukemia Is Associated With Drug Resistance and is Independent of MDR1/MDR3 Gene Expression. Blood 1993; 82: 3452–3459
   PubMed Web of Science ®Google Scholar
• Morabito F, Filangeri M, Callea I, Sculli G, Gallea V, Frac-chiola N S, Neri A, Brugiatelli M. bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chloramb-bucil and purine analogs. Haematoolgica 1997; 82: 16–20
   PubMedGoogle Scholar
• Agular-Santelises M, Rottenberg M E, Lewin N, Mellstedt H, Jondal M. Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression. Intern Journal aCncer 1996; 69: 114–119
   PubMed Web of Science ®Google Scholar
• Cano I, Martinez J, Quevedo F., Pinilla J, Martin-Recio A, Rodriguez A, Castaneda A, Lopez R, Perez-Pino T, Hernan-dez-Navarro F. Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: association with morphology and resistance to conventional chemotherapy. Cancer Genetics Cyto-egtics 1996; 90: 118–124
   PubMed Web of Science ®Google Scholar
• Neilson J R, Auer R, Fegan C D, Milligan D W. P53 mutations in B-cell chronic lympocytic leukemia: prevalence, persistence and relation to karyotype and clinical features. VII International Workshop on CLL, abstrac tbook 1997; 22: 2–4
   Google Scholar
• Garcia-Marco J. A. The cytogenetics of CLL. VII International Workshop on CLL, abstrac tbook 1997; 11: 2–4
   Google Scholar